Methenamine Hippurate Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Methenamine Hippurate Tablets contain NLT 95.0% and NMT 105.0% of the labeled amount of methenamine hippurate (C6H12N4 · C9H9NO3).
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197M (CN 1-May-2020)
Sample: A portion of finely powdered Tablets
Acceptance criteria: Meet the requirements
3 ASSAY
Procedure
Sample solution: Transfer an equivalent to 700 mg of methenamine hippurate from finely powdered Tablets (NLT 20) to a 250-mL conical flask. Add 50 mL of alcohol, then add thymolphthalein TS.
Titrimetric system
Mode: Direct titration
Titrant: 0.1 N sodium hydroxide VS
Endpoint detection: Visual
Analysis: Titrate the Sample solution with Titrant. Perform a blank determination on a mixture of 50 mL of alcohol and 20 mL of water, and
make any necessary correction. Each mL of 0.1 N sodium hydroxide is equivalent to 31.94 mg of methenamine hippurate (C6H12N4 · C9H9NO3).
Acceptance criteria: 95.0%–105.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
Test 1
Medium: Water; 900 mL
Apparatus 2: 100 rpm
Time: 30 min
Standard solution: 22 μg/mL of USP Methenamine Hippurate RS
Instrumental conditions
Mode: UV
Analytical wavelength: Maxima at about 227 nm
Analysis: Determine the quantity of methenamine hippurate (C6H12N4 · C9H9NO3) dissolved of filtered portions of the solution under test, suitably diluted with water if necessary, in comparison with the Standard solution.
Tolerances: NLT 80% (Q) of the labeled amount of methenamine hippurate (C6H12N4 · C9H9NO3) is dissolved.
Test 2
[Note—If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.]
Medium: Water; 900 mL
Apparatus 2: 50 rpm
Time: 60 min
Standard solution: 22 μg/mL of USP Methenamine Hippurate RS
Instrumental conditions
Mode: UV
Analytical wavelength: Maxima at about 227 nm
Analysis: Determine the quantity of methenamine hippurate (C6H12N4 · C9H9NO3) dissolved of filtered portions of the solution under test, suitably diluted with water if necessary, in comparison with the Standard solution.
Tolerances: NLT 80% (Q) of the labeled amount of methenamine hippurate (C6H12N4 · C9H9NO3) is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers.
Labeling: When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
USP Reference Standards 〈11〉
USP Methenamine Hippurate RS

